Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss

K Ichimura, Maria Bondesson Bolin, Helena M Goike, Esther E Schmidt, Ahmad Moshref, V Peter Collins, Deregulation of the p14ARF/MDM2/p53 Pathway Is a Prerequisite for Human Astrocytic Gliomas with G1-S Transition Control Gene Abnormalities Cancer Research. ,vol. 60, pp. 417- 424 ,(2000)

Yonehiro Kanemura, Hirotaka Matsumura, Shoju Hiraga, Norio Arita, Takanori Ohnishi, Eiji Miyahara, Shuichi Izumoto, Telomerase Activity and Alterations in Telomere Length in Human Brain Tumors Cancer Research. ,vol. 58, pp. 2117- 2125 ,(1998)

Norman E. Breslow, Tracy Bergemann, Christopher B. Umbricht, Elizabeth J. Perlman, Saraswati Sukumar, Paul E. Grundy, Seung Chung, Motoyasu Saji, Lisa A. Carey, Lisa A. Carey, Jeffrey S. Dome, High Telomerase Reverse Transcriptase (hTERT) Messenger RNA Level Correlates with Tumor Recurrence in Patients with Favorable Histology Wilms’ Tumor Cancer Research. ,vol. 59, pp. 4301- 4307 ,(1999)

Yuchen Jiao, Patrick J. Killela, Zachary J. Reitman, B. Ahmed Rasheed, Christopher M. Heaphy, Roeland F. de Wilde, Fausto J. Rodriguez, Sergio Rosemberg, Sueli Mieko Oba-Shinjo, Suely Kazue Nagahashi Marie, Chetan Bettegowda, Nishant Agrawal, Eric Lipp, Christopher J. Pirozzi, Giselle Y. Lopez, Yiping He, Henry S. Friedman, Allan H. Friedman, Gregory J. Riggins, Matthias Holdhoff, Peter Burger, Roger E. McLendon, Darell D. Bigner, Bert Vogelstein, Alan K. Meeker, Kenneth W. Kinzler, Nickolas Papadopoulos, Luis A. Diaz, Hai Yan, Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget. ,vol. 3, pp. 709- 722 ,(2012) , 10.18632/ONCOTARGET.588

YOSHIKO OKITA, YOSHITAKA NARITA, YASUJI MIYAKITA, MAKOTO OHNO, YUKO MATSUSHITA, SHINTARO FUKUSHIMA, MINAKO SUMI, KOICHI ICHIMURA, TAKAMASA KAYAMA, SOICHIRO SHIBUI, IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy International Journal of Oncology. ,vol. 41, pp. 1325- 1336 ,(2012) , 10.3892/IJO.2012.1564

Siyuan Le, Jay Jiguang Zhu, Douglas C. Anthony, Carol W. Greider, Peter McL. Black, Telomerase Activity in Human Gliomas Neurosurgery. ,vol. 42, pp. 1120- 1125 ,(1998) , 10.1097/00006123-199805000-00099

L. Boldrini, S. Pistolesi, S. Gisfredi, S. Ursino, G. Ali, N. Pieracci, F. Basolo, G. Parenti, G. Fontanini, Telomerase activity and hTERT mRNA expression in glial tumors. International Journal of Oncology. ,vol. 28, pp. 1555- 1560 ,(2006) , 10.3892/IJO.28.6.1555

T Sano, A Asai, K Mishima, T Fujimaki, T Kirino, Telomerase activity in 144 brain tumours. British Journal of Cancer. ,vol. 77, pp. 1633- 1637 ,(1998) , 10.1038/BJC.1998.267

Takao Fukushima, Atsuo Yoshino, Yoichi Katayama, Takao Watanabe, Kaoru Kusama, Itaru Moro, Prediction of clinical course of diffusely infiltrating astrocytomas from telomerase expression and quantitated activity level. Cancer Letters. ,vol. 187, pp. 191- 198 ,(2002) , 10.1016/S0304-3835(02)00357-9

Stephen Yip, Yaron S Butterfield, Olena Morozova, Suganthi Chittaranjan, Michael D Blough, Jianghong An, Inanc Birol, Charles Chesnelong, Readman Chiu, Eric Chuah, Richard Corbett, Rod Docking, Marlo Firme, Martin Hirst, Shaun Jackman, Aly Karsan, Haiyan Li, David N Louis, Alexandra Maslova, Richard Moore, Annie Moradian, Karen L Mungall, Marco Perizzolo, Jenny Qian, Gloria Roldan, Eric E Smith, Jessica Tamura-Wells, Nina Thiessen, Richard Varhol, Samuel Weiss, Wei Wu, Sean Young, Yongjun Zhao, Andrew J Mungall, Steven JM Jones, Gregg B Morin, Jennifer A Chan, J Gregory Cairncross, Marco A Marra, Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers. The Journal of Pathology. ,vol. 226, pp. 7- 16 ,(2012) , 10.1002/PATH.2995